“MIT researchers have created a schizophrenic mouse that pinpoints a gene variation predisposing people to schizophrenia. Research with the mouse may lead to the first genetically targeted drugs for the disease, which affects 1 percent of the population worldwide. This is the first study that uses animals who demonstrate an array of symptoms observed in schizophrenic patients to identify specific genes that predispose people to the disease.”